Channel profile image
Featured Speakers
Anthony Kerbage's photo
Anthony Kerbage
Shivangini Duggal's photo
Shivangini Duggal
Tom Wallach's photo
Tom Wallach
Talks (119)
IBSsurvey_8
Aug 29
IBSsurvey_7
Aug 29
IBSsurvey_6
Aug 29
IBSsurvey_5
Aug 29
IBSsurvey_4
Aug 29
IBSsurvey_3
Aug 29
IBSsurvey_2
Aug 29
IBSsurvey_1
Aug 29
IBSD Rifaximin MMX 10
Jul 31
IBSD Rifaximin MMX 9
Jul 31
IBSD Rifaximin MMX 8
Jul 31
IBSD Rifaximin MMX 7
Jul 31
IBSD Rifaximin MMX 6
Jul 31
IBSD Rifaximin MMX 5
Jul 31
IBSD Rifaximin MMX 4
Jul 31
IBSD Rifaximin MMX 3
Jul 31
IBSD Rifaximin MMX 2
Jul 31
IBSD Rifaximin MMX 1
Jul 31
Advancing Precision Medicine in IBS
Jul 27
Usability and Compliance
Jul 27
Reducing Bias Through Real-Time Data
Jul 27
Capturing Symptom Interactions
Jul 27
Reliability Despite Symptom Variability
Jul 27
Internal Consistency Across Symptom Doma
Jul 27
Weaker Correlations With End-of-Week Too
Jul 27
Retrospective Bias in End-of-Day Diaries
Jul 27
High Adherence Supports ESM Feasibility
Jul 19
Validating Real-Time Symptom Assessment
Jul 19
Intestinal Persistence SARS-CoV2
Jul 10
IBS_ Mediterranean10
Jun 19
IBS_ Mediterranean9
Jun 19
IBS_ Mediterranean8
Jun 19
IBS_ Mediterranean7
Jun 19
IBS_ Mediterranean6
Jun 19
IBS_ Mediterranean5
Jun 19
IBS_ Mediterranean4
Jun 19
IBS_ Mediterranean3
Jun 19
IBS_ Mediterranean2
Jun 19
IBS_ Mediterranean1
Jun 19
Microbiome and IBS therapies
May 27
Microbiome and IBS therapies
May 27
Low FODMAP and microbiome
May 27
Low FODMAP & Microbiome Metabotype
May 27
Restrictive dietary patterns
May 27
Diet & short chain fatty acids
May 27
Short chain fatty acids & IBS
May 27
Short chain fatty acids & IBS
May 27
Microbiome in IBS-2
May 27
Microbiome changes in IBS
May 27
RifaximinNAC_10
May 26
RifaximinNAC_9
May 26
RifaximinNAC_8
May 26
RifaximinNAC_7
May 26
RifaximinNAC_6
May 26
RifaximinNAC_5
May 26
RifaximinNAC_4
May 26
RifaximinNAC_3
May 26
RifaximinNAC_2
May 26
RifaximinNAC_1
May 26
Future of AI in IBS
May 01
Loading logo